Wyss Zurich
VC Fund
Wyss Zurich is a joint accelerator of the University of Zurich and ETH Zurich (Swiss Federal Institute of Technology Zurich), which was made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. h.c. mult. Hansjörg Wyss. It was established to foster translational research focused on developing treatment protocols andclinical therapies, as well as novel technologies and intelligent systems, in the emerging fields of Regenerative Medicine and Robotics, and hybrid technologies thereof.Wyss Zurich unites world-leading experts from both institutions in multidisciplinary teams, pooling their knowledge and expertise.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Wyss Zurich invests in
Stages Wyss Zurich invests in
Countries Wyss Zurich invests in
Investment Focus
Industry
- Robotics 2 (50%)
- Health Care 2 (50%)
- Medical 1 (25%)
- Broadcasting 1 (25%)
- Life Science 1 (25%)
Stage
- Seed 2 (50%)
- Series A 1 (25%)
- Non-equity Assistance 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Tandem Therapeutics
|
Tandem Therapeutics develops peptide therapeutics that target and treat the extracellular matrix barrier. | Non-equity Assistance / Apr 12, 2024 | |
MUVON Therapeutics
|
Muvon Therapeutics platform helps women with urinary incontinence and treats diseases based on skeletal muscle degradation, supporting them in their commitment to living a healthy life. The company's mode of contact is by mail, phone, and physical address. | Series A / May 31, 2021 | |
Nanoflex Robotics
|
Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland. | $7.9M / Seed / May 01, 2021 | |
Seervision AG
|
Seervision is a Swiss startup developing innovative software that makes video production automated and effortless. Originally founded at ETH Zurich, what started as an idea to improve live lecture recording has grown into a flourishing startup with over 30 employees. Nowadays, the Seervision Suite is primarily focused on automating the overallworkflow of corporate studios, stage events and, not forgetting where they started, educational spaces. Their system now seamlessly integrates with the entire ecosystem of a corporate environment or stage event to automate and simplify live production workflows. | $3.5M / Seed / Jun 11, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Wyss Zurich invest in?
Wyss Zurich invests primarily in Robotics, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Wyss Zurich last invest?
The most recent investment recorded for Wyss Zurich closed in Apr 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
